NEAR-TOTAL REDUCTION IN VERAPAMIL BIOAVAILABILITY BY RIFAMPIN - ELECTROCARDIOGRAPHIC CORRELATES

被引：29

作者：

BARBARASH, RA

BAUMAN, JL

FISCHER, JH

KONDOS, GT

BATENHORST, RL

机构：

[1] UNIV ILLINOIS,DEPT PHARM PRACTICE,CLIN PHARMACOKINET LAB,CHICAGO,IL 60612

[2] UNIV ILLINOIS,DEPT MED,CARDIOL SECT,CHICAGO,IL 60612

[3] WASHINGTON UNIV,JEWISH HOSP ST LOUIS,DIV CARDIOL,ST LOUIS,MO 63110

来源：

CHEST | 1988年 / 94卷 / 05期

关键词：

D O I：

10.1378/chest.94.5.954

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：954 / 959

页数：6

共 29 条

[1] RIFAMPIN DRUG-INTERACTIONS [J].

BACIEWICZ, AM ;

SELF, TH .

ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (08) :1667-1671

[2] UPDATE ON RIFAMPIN DRUG-INTERACTIONS [J].

BACIEWICZ, AM ;

SELF, TH ;

BEKEMEYER, WB .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (03) :565-568

[3] VERAPAMIL INFUSIONS IN THE TREATMENT OF ATRIAL TACHYARRHYTHMIAS [J].

BARBARASH, RA ;

BAUMAN, JL ;

LUKAZEWSKI, AA ;

SREBRO, JP ;

RICH, S .

CRITICAL CARE MEDICINE, 1986, 14 (10) :886-888

[4] VERAPAMIL-RIFAMPIN INTERACTION [J].

BARBARASH, RA .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (7-8) :559-560

[5] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[6]

BREIMER DD, 1977, CLIN PHARMACOL THER, V21, P470

[7] CLINICAL PHARMACOKINETICS OF VERAPAMIL, NIFEDIPINE AND DILTIAZEM [J].

ECHIZEN, H ;

EICHELBAUM, M .

CLINICAL PHARMACOKINETICS, 1986, 11 (06) :425-449

[8]

FARR B, 1985, PRINCIPLES PRACTICE, P216

[9]

GIBALDI M, 1982, PHARMACOKINETICS

[10] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF VERAPAMIL .2. SIMULTANEOUS QUANTITATION OF VERAPAMIL AND ITS ACTIVE METABOLITE, NORVERAPAMIL [J].

HARAPAT, SR ;

KATES, RE .

JOURNAL OF CHROMATOGRAPHY, 1980, 181 (3-4) :484-489

← 1 2 3 →